Coronary Artery Disease (CAD)
The purpose of this study is to evaluate the effectiveness and safety of hybrid coronary revascularization (HCR) compared to multi-vessel percutaneous cardiac intervention (PCI) with metallic drug-eluting stents (DES) in patients with multi-vessel coronary artery disease (CAD) involving the left anterior descending (LAD) and/or left main (LM) arteries.
Principal Investigators: Robert L. Smith, II, MD / Molly Szerlip, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
IRB Number: 017-097
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating may change your care
Rachelle Winkle, RN469.814.4183Rachelle.Winkle@BSWHealth.org
Heath Shirkey, RN469.814.4185Heath.Shirkey@BSWHealth.org
Randomized Trial of Hybrid Coronary Revascularization versus Percutaneous Coronary Intervention
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.